These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33259227)

  • 41. Direct oral anticoagulants in the treatment of pulmonary embolism.
    Eldredge JB; Spyropoulos AC
    Curr Med Res Opin; 2018 Jan; 34(1):131-140. PubMed ID: 28771049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The CVRN VTE Study.
    Fang MC; Fan D; Sung SH; Witt DM; Schmelzer JR; Williams MS; Yale SH; Baumgartner C; Go AS
    Am J Med; 2019 Dec; 132(12):1450-1457.e1. PubMed ID: 31247183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients.
    Font C; Carmona-Bayonas A; Fernández-Martinez A; Beato C; Vargas A; Gascon P; Otero R
    J Natl Compr Canc Netw; 2014 Mar; 12(3):365-73. PubMed ID: 24616542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic role of the simplified pulmonary embolism severity index and shock index in pulmonary embolism.
    Kilic T; Ermis H; Gülbas G; Kaya O; Aytemur ZA; Inceoglu F; Hacievliyagil SS
    Pol Arch Med Wewn; 2014; 124(12):678-87. PubMed ID: 25311492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Frymire E; Khan S; Johnson AP;
    Thromb Res; 2019 Oct; 182():12-19. PubMed ID: 31434018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting.
    Henk HJ; Cao F; Tuell K; Price K; Singh P; Mardekian J; Odell K; Patel C; Tan W; Sands GH; Singhal S; Trocio J; Vo L
    Curr Med Res Opin; 2018 Mar; 34(3):539-546. PubMed ID: 29235900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Spirk D; Aujesky D; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Nov; 106(5):978-84. PubMed ID: 21833454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Best Clinical Practice: Controversies in Outpatient Management of Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2017 May; 52(5):668-679. PubMed ID: 28007362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
    Amin AN; Lin J; Thompson S; Wiederkehr D
    Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis.
    Groetzinger LM; Miller TJ; Rivosecchi RM; Smith RE; Gladwin MT; Rivera-Lebron BN
    Clin Appl Thromb Hemost; 2018 Sep; 24(6):908-913. PubMed ID: 29455567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of two clinical prognostic models in patients with acute symptomatic pulmonary embolism.
    Ferrer M; Morillo R; Elías T; Jara L; García L; Nieto R; Sandoval E; Uresandi F; Otero R; Jiménez D
    Arch Bronconeumol; 2013 Oct; 49(10):427-31. PubMed ID: 23664248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.
    Wells PS; Kovacs MJ; Bormanis J; Forgie MA; Goudie D; Morrow B; Kovacs J
    Arch Intern Med; 1998 Sep; 158(16):1809-12. PubMed ID: 9738611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.
    Blin P; Samama CM; Sautet A; Benichou J; Lignot-Maleyran S; Lamarque S; Lorrain S; Lassalle R; Droz-Perroteau C; Mismetti P; Moore N
    Pharmacol Res; 2019 Mar; 141():201-207. PubMed ID: 30583081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and economic burden of pulmonary embolism in Germany.
    Kröger K; Küpper-Nybelen J; Moerchel C; Moysidis T; Kienitz C; Schubert I
    Vasc Med; 2012 Oct; 17(5):303-9. PubMed ID: 22751745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient treatment of pulmonary embolism.
    Aujesky D; Mazzolai L; Hugli O; Perrier A
    Swiss Med Wkly; 2009 Nov; 139(47-48):685-90. PubMed ID: 20047130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
    Vinson DR; Ballard DW; Mark DG; Huang J; Reed ME; Rauchwerger AS; Wang DH; Lin JS; Kene MV; Pleshakov TS; Sax DK; Sax JM; McLachlan DI; Yamin CK; Swap CJ; Iskin HR; Vemula R; Fleming BS; Elms AR; Aujesky D;
    Thromb Res; 2016 Dec; 148():1-8. PubMed ID: 27764729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
    Barco S; Schmidtmann I; Ageno W; Bauersachs RM; Becattini C; Bernardi E; Beyer-Westendorf J; Bonacchini L; Brachmann J; Christ M; Czihal M; Duerschmied D; Empen K; Espinola-Klein C; Ficker JH; Fonseca C; Genth-Zotz S; Jiménez D; Harjola VP; Held M; Iogna Prat L; Lange TJ; Manolis A; Meyer A; Mustonen P; Rauch-Kroehnert U; Ruiz-Artacho P; Schellong S; Schwaiblmair M; Stahrenberg R; Westerweel PE; Wild PS; Konstantinides SV; Lankeit M;
    Eur Heart J; 2020 Jan; 41(4):509-518. PubMed ID: 31120118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy.
    Dasta JF; Pilon D; Mody SH; Lopatto J; Laliberté F; Germain G; Bookhart BK; Lefebvre P; Nutescu EA
    Thromb Res; 2015 Feb; 135(2):303-10. PubMed ID: 25555319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy.
    Wong CC; Ng AC; Lau JK; Chow V; Chen V; Ng AC; Yong AS; Sindone AP; Marwick TH; Kritharides L
    Thromb Haemost; 2016 Jun; 115(6):1191-9. PubMed ID: 26843127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.